Adrian Israelson

Department of Physiology and Cell Biology, Ben-Gurion University of the Negev

Affiliated withBen-Gurion University of the Negev

Research Area

Biography

Adrian Israelson has not added Biography.
If you are Adrian Israelson and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 6	2017

Other Publications

Article	Year
A chemical chaperone-based drug candidate is effective in a mouse model of amyotrophic lateral sclerosis (ALS). ChemMedChem\| PubMed ID: 25772747	2015
In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. The Biochemical journal\| PubMed ID: 14561215	2004
Oligomeric states of the voltage-dependent anion channel and cytochrome c release from mitochondria. The Biochemical journal\| PubMed ID: 15456403	2005
Fluoxetine (Prozac) interaction with the mitochondrial voltage-dependent anion channel and protection against apoptotic cell death. FEBS letters\| PubMed ID: 16139271	2005
A photoactivable probe for calcium binding proteins. Chemistry & biology\| PubMed ID: 16298296	2005
Localization of the voltage-dependent anion channel-1 Ca2+-binding sites. Cell calcium\| PubMed ID: 16930689	2007
Azido ruthenium: a new photoreactive probe for calcium-binding proteins. Nature protocols\| PubMed ID: 17406221	2006
Mapping the ruthenium red-binding site of the voltage-dependent anion channel-1. Cell calcium\| PubMed ID: 17590433	2008
Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding. The Journal of biological chemistry\| PubMed ID: 18308720	2008
The VDAC1 N-terminus is essential both for apoptosis and the protective effect of anti-apoptotic proteins. Journal of cell science\| PubMed ID: 19461077	2009
Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron\| PubMed ID: 20797535	2010
ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 21078990	2010
New fluorescent reagents specific for Ca(2+)-binding proteins. Biochemical and biophysical research communications\| PubMed ID: 22925895	2012
Why lithium studies for ALS treatment should not be halted prematurely. Frontiers in neuroscience\| PubMed ID: 25228854	2014
Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1. Neuron\| PubMed ID: 25801706	2015
Macrophage migration inhibitory factor as a component of selective vulnerability of motor neurons in ALS. Rare diseases (Austin, Tex.)\| PubMed ID: 26459694	2015
Superoxide Dismutase 1 (SOD1)-Derived Peptide Inhibits Amyloid Aggregation of Familial Amyotrophic Lateral Sclerosis SOD1 Mutants. ACS chemical neuroscience\| PubMed ID: 27540759	2016
Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 27551074	2016